HOW DOES INNOVATIVE CANCER SOLUTIONS PROVIDE THE SOLUTION?
ICS Therapy is a leading technology within the growing field of non-invasive or minimally invasive medical technology. Its capacity to generate precise tissue necrosis, with no effect on surrounding tissue, and with no marks on nearby skin, is unique. ICS Thera began in the 1950s, and will evolve to become an integral part of medicine today. ICS Therapy utilizes ultrasonic waves -- the same waves that pass harmlessly through a pregnant woman and her fetus during a sonogram. In the same manner a magnifying lens focuses sunlight to start a fire, HIFU focuses ordinary ultrasound waves into tumours, raising the temperature high enough to denature cell proteins and bring about cellular death. The absorbed energy results in extremely high tissue gradients between target cells and surrounding tissue, so the effect of the focused energy is concentrated only at the target, leaving the healthy tissue unscathed.
HOW EFFECTIVE IS IT?
ICS technology has been developed over more than 15 years and has been used to treat over 7,000 cancer patients throughout Asia with a 70+% success rate at tumour removal with virtually no lasting side effects. The process achieved European CE mark safety approval in 2005. Patients will also benefit dramatically after receiving HIFU Therapy because after treatment, as Prof. Slavin pointed out and Dr. Ayoub proves, the circulation of the debris from the destruction of the tumour actually creates an increased cancer immune response in the body making the patient more resistant to future tumour development. This shows up in clinical trials where patients have fewer cancers 6, 12 or 18 months after treatment than those treated with surgery.